Processa Pharmaceuticals, Inc. Major Shareholders & Ownership History
| Major Shareholder Name | Reporting Date | Shares Held | Market Value | Change in Shares | Ownership |
|---|---|---|---|---|---|
| CITADEL ADVISORS LLC | 02/14/2024 | 315.41 K | $105.54 K | 89.75% | 1.17% |
| VANGUARD GROUP INC | 03/11/2024 | 234.65 K | $78.52 K | -31.87% | 0.87% |
| GEODE CAPITAL MANAGEMENT, LLC | 02/13/2024 | 122.03 K | $40.83 K | -20.07% | 0.45% |
| UBS GROUP AG | 02/09/2024 | 80.02 K | $26.81 K | 11,218.67% | 0.30% |
| SPINNAKER TRUST | 02/02/2024 | 76.87 K | $25.72 K | 100.00% | 0.28% |
| COASTAL BRIDGE ADVISORS, LLC | 02/15/2024 | 64.96 K | $21.73 K | 23.73% | 0.24% |
| RENAISSANCE TECHNOLOGIES LLC | 02/13/2024 | 58.20 K | $19.00 K | 7.98% | 0.22% |
| ROYAL BANK OF CANADA | 02/14/2024 | 46.31 K | $15.00 K | -0.16% | 0.17% |
| STATE STREET CORP | 02/14/2024 | 42.79 K | $14.32 K | 0.00% | 0.16% |
| NORTHERN TRUST CORP | 02/13/2024 | 28.14 K | $9.42 K | 82.71% | 0.10% |
| TWO SIGMA INVESTMENTS, LP | 02/14/2024 | 18.68 K | $6.25 K | 100.00% | 0.07% |
| MCCOLLUM CHRISTOFERSON GROUP LLC | 01/19/2024 | 12.50 K | $4.18 K | 100.00% | 0.05% |
| COURIER CAPITAL LLC | 01/17/2024 | 12.00 K | $4.02 K | 100.00% | 0.04% |
| HRT FINANCIAL LP | 02/09/2024 | 11.72 K | $3.00 K | -39.43% | 0.04% |
| WELLS FARGO & COMPANY/MN | 02/09/2024 | 3.25 K | $1.09 K | 0.28% | 0.01% |
| ALLWORTH FINANCIAL LP | 01/24/2024 | 1.70 K | $569 | 0.00% | 0.01% |
| TOWER RESEARCH CAPITAL LLC (TRC) | 02/13/2024 | 1.20 K | $400 | -88.16% | 0.00% |
| BLACKROCK INC. | 02/13/2024 | 293 | $98 | 0.00% | 0.00% |
| JPMORGAN CHASE & CO | 12/26/2024 | 0 | $0 | -100.00% | 0.00% |
| MILLENNIUM MANAGEMENT LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
| VIRTU FINANCIAL LLC | 02/26/2024 | 0 | $0 | -100.00% | 0.00% |
| MACROVIEW INVESTMENT MANAGEMENT LLC | 01/30/2024 | 0 | $0 | -100.00% | 0.00% |
| MIRADOR CAPITAL PARTNERS LP | 01/19/2024 | 0 | $0 | -100.00% | 0.00% |
| WALLEYE CAPITAL LLC | 02/14/2024 | 0 | $0 | -100.00% | 0.00% |
Explore Related Stocks for Market Trends
Explore our related stocks for the latest market trends and stock news to stay informed and make better decisions.
Processa Pharmaceuticals, Inc. institutional Ownership - FAQ's
4.19% of Processa Pharmaceuticals, Inc. stock is owned by institutional investors.